Pregabalin sustained-release preparation
US10258584B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2015 |
| Grant date | Apr 16, 2019 |
| Priority date | — |
| Expiry date | Sep 30, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a pregabalin sustained-release preparation, wherein the sustained-release tablet contains a pharmaceutically active ingredient containing pregabalin or a salt or hydrate thereof, a gel framework material containing alginic acid, and a swellable material containing polyoxyethylene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.